Published August 1990 | Version v1
Report Open

Progress in neutron beam development at the HFR Petten (feasibility study for a BNCT facility)

  • 1. JRC Petten (Netherlands)
  • 2. AEA Technology, Harwell (United Kingdom)
  • 3. Birmingham Univ. (UK)
  • 4. Netherlands Energy Research Foundation, Petten (Netherlands)

Description

Boron Neutron Capture Therapy, using intermediate energy neutrons to achieve the deep penetration essential for treating brain tumours, can be implemented with a filtered reactor neutron beam. This is designed to minimize the mean energy of the neutrons to keep proton recoil damage to the scalp within normal tissue tolerance limits whilst delivering the required thermal neutron fluence to the tumour over a reasonably short period. This can only be realized in conjunction with a high power density reactor. At the Joint Research Centre Petten an optimized neutron filter is currently being built for installation into the HB11 beam tube of the High Flux Reactor HFR. Part of the development leading to this design has been an extensive study of broad spectrum, filtered beam performance on the HB7 beam tube facility. A wide range of calculations was performed using the Monte Carlo code, MCPN, supported by validation experiments in which several filter configuration incorporating aluminium, sulphur, liquid argon, titanium and cadmium were installed for low power measurements of the neutron fluence rate, neutron spectra and beam gamma-ray contamination. The measurements were carried out within a successful European collaboration. Evaluations were made of the reactor core edge and unfiltered beam spectra, for comparison with MCNP calculations. Multi-foil activation methods and also gamma dose determination in the filtered beam using thermo-luminescent detectors were performed by the ECN. The Harwell/ Birmingham University collaborators undertook the neutron spectrum measurements in the filtered beam. proton recoil spectrometry was used above 30 keV, combined with a multi-sphere and BF3 chamber response modification technique. Subsequent spectrum adjustment was carried out with the SENSAK code. The agreement between the calculated and measured spectra has given confidence in the reactor and filter modelling methods used to design the HB11 therapy facility. (author). 12 refs.; 6 figs.; 4 tabs

Availability note (English)

MF available from INIS under the Report Number.

Files

22034367.pdf

Files (518.1 kB)

Name Size Download all
md5:4fabf9d96177e2fb7215b63e380410e8
518.1 kB Preview Download

Additional details

Publishing Information

Imprint Pagination
15 p.
Report number
ECN-RX--90-058

Conference

Title
7. ASTM-Euratom symposium on reactor dosimetry.
Dates
27-31 Aug 1990.
Place
Strasbourg (France).

Optional Information

Notes
Submitted for publication.